Literature DB >> 8159719

Electron micrographic studies of transport of oligodeoxynucleotides across eukaryotic cell membranes.

P Zamecnik1, J Aghajanian, M Zamecnik, J Goodchild, G Witman.   

Abstract

Unmodified oligodeoxynucleotides (ODNs) were synthesized and tested for their ability to cross external eukaryotic cell membranes and to enter the cytosol and nucleus in tissue cultures. The ODNs were labeled with high-specific-activity [3H]thymidine (> or = 100 Ci/mmol), or [ alpha-32P]ATP or [ gamma-32P]ATP (300-1000 Ci/mmol; 1 Ci = 37 GBq), and the label was either in the central portion of the molecule or at the 3' or 5' end. The cells employed were for the most part 3T6 murine fibroblasts, grown in monolayers, either semiconfluent or confluent, but some experiments were carried out with chicken embryo fibroblasts or human HeLa cells. Parallel wells in the same experiment were prepared for electron microscopy or for cell fractionation and radioactivity assays. Electron microscopic autoradiography indicated that ODNs cross the external cell membrane, traverse the cytosol, and begin to enter the cell nucleus within a few seconds to 5 min at 37 degrees C in Dulbecco's medium without added serum. After 30-60 min of incubation with ODNs, abundant silver grains were observed at or just inside the nuclear membrane or well distributed across the nucleus, particularly in association with euchromatin. There was a paucity of silver grains associated with nucleoli. Cell entry of oligomer was related to cell cycling events and was energy dependent. Degradation of oligomer to monomers, with reincorporation into DNA, does not appear to explain these results. No sequestration of labeled oligomer in cytoplasmic vesicles en route from the exterior of the cell to the nucleus was observed. The observations are more suggestive of internalization of oligonucleotide by a mechanism as yet unclear or, alternatively, by a caveolar, potocytotic mechanism rather than by endocytosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8159719      PMCID: PMC43534          DOI: 10.1073/pnas.91.8.3156

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Cellular uptake and intracellular fate of antisense oligonucleotides.

Authors:  S Akhtar; R L Juliano
Journal:  Trends Cell Biol       Date:  1992-05       Impact factor: 20.808

2.  Nuclear DNA polymerases and the HeLa cell cycle.

Authors:  R W Chiu; E F Baril
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

3.  RNA. Deviants--or emissaries.

Authors:  M Wickens; K Takayama
Journal:  Nature       Date:  1994-01-06       Impact factor: 49.962

4.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Authors:  P C Zamecnik; M L Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

5.  Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.

Authors:  M L Stephenson; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

6.  Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

Authors:  P C Zamecnik; J Goodchild; Y Taguchi; P S Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

7.  Antisense c-myc oligodeoxyribonucleotide cellular uptake.

Authors:  S Wu-Pong; T L Weiss; C A Hunt
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

8.  Oligonucleotides with rapid turnover of the phosphate groups occur endogenously in eukaryotic cells.

Authors:  P Plesner; J Goodchild; H M Kalckar; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

9.  Cellular uptake of phosphorothioate oligodeoxynucleotides is negatively affected by cell density in a transformed rat tracheal epithelial cell line: implication for antisense approaches.

Authors:  T Iwanaga; P C Ferriola
Journal:  Biochem Biophys Res Commun       Date:  1993-03-31       Impact factor: 3.575

10.  Differentiated microdomains on the luminal surface of capillary endothelium: distribution of lectin receptors.

Authors:  M Simionescu; N Simionescu; G E Palade
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539

View more
  10 in total

1.  Direct observation of specific messenger RNA in a single living cell under a fluorescence microscope.

Authors:  A Tsuji; H Koshimoto; Y Sato; M Hirano; Y Sei-Iida; S Kondo; K Ishibashi
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

2.  Patterns of intracellular compartmentalization, trafficking and acidification of 5'-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells.

Authors:  J L Tonkinson; C A Stein
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

3.  Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

Authors:  C Beltinger; H U Saragovi; R M Smith; L LeSauteur; N Shah; L DeDionisio; L Christensen; A Raible; L Jarett; A M Gewirtz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Use of a Pteridine Moiety to Track DNA Uptake in Cells.

Authors:  Justin A Costa; Edgar Leal-Pinto; Scott C Henderson; Troy Zabel; Mary E Hawkins; Basil Hanss
Journal:  Pteridines       Date:  2013-08       Impact factor: 0.581

5.  In vivo suppression of the renal Na+/Pi cotransporter by antisense oligonucleotides.

Authors:  R Oberbauer; G F Schreiner; J Biber; H Murer; T W Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

6.  Characterization of hybridization between synthetic oligodeoxynucleotides and RNA in living cells.

Authors:  J C Politz; K L Taneja; R H Singer
Journal:  Nucleic Acids Res       Date:  1995-12-25       Impact factor: 16.971

7.  Qualitative and quantitative characteristics of the extracellular DNA delivered to the nucleus of a living cell.

Authors:  Vladimir A Rogachev; Anastasia Likhacheva; Oksana Vratskikh; Lyudmila V Mechetina; Tamara E Sebeleva; Sergei S Bogachev; Leonid A Yakubov; Mikhail A Shurdov
Journal:  Cancer Cell Int       Date:  2006-10-11       Impact factor: 5.722

Review 8.  The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides.

Authors:  Traian V Chirila; Piroska E Rakoczy; Kerryn L Garrett; Xia Lou; Ian J Constable
Journal:  Biomaterials       Date:  2002-01       Impact factor: 12.479

9.  Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.

Authors:  Moizza Mansoor; Alirio J Melendez
Journal:  Gene Regul Syst Bio       Date:  2008-09-22

Review 10.  Innovations in oligonucleotide drug delivery.

Authors:  Melanie A Lysik; Susanna Wu-Pong
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.